Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
about
Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regenerationRecent advances in managing a spinal cord injury secondary to traumaEngineering therapies in the CNS: what works and what can be translatedFibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applicationsEngineering the matrix microenvironment for cell delivery and engraftment for tissue repairBiomaterial-based interventions for neuronal regeneration and functional recovery in rodent model of spinal cord injury: a systematic reviewA review of bioactive release from nerve conduits as a neurotherapeutic strategy for neuronal growth in peripheral nerve injuryStrain tunes proteolytic degradation and diffusive transport in fibrin networksManipulation of hydrogel assembly and growth factor delivery via the use of peptide-polysaccharide interactionsBiomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord.Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCIHydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration.Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injuryBiomaterials that regulate growth factor activity via bioinspired interactions.Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model.An overview of tissue engineering approaches for management of spinal cord injuries.Diffusion of insulin-like growth factor-I and ribonuclease through fibrin gelsNanofibrous collagen nerve conduits for spinal cord repairApproaches to neural tissue engineering using scaffolds for drug deliveryHyaluronic acid-based scaffold for central neural tissue engineeringGene delivery from polymer scaffolds for tissue engineering.The potential for cellular therapy combined with growth factors in spinal cord injury.Finely Tuned Temporal and Spatial Delivery of GDNF Promotes Enhanced Nerve Regeneration in a Long Nerve Defect ModelCell therapy for spinal cord regenerationInductive tissue engineering with protein and DNA-releasing scaffoldsProtein-hydrogel interactions in tissue engineering: mechanisms and applications.Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury.Controlled release of neurotrophin-3 from fibrin-based tissue engineering scaffolds enhances neural fiber sprouting following subacute spinal cord injury.Fibrin-based tissue engineering scaffolds enhance neural fiber sprouting and delay the accumulation of reactive astrocytes at the lesion in a subacute model of spinal cord injury.Effects of immobilized glycosaminoglycans on the proliferation and differentiation of mesenchymal stem cells.Three-dimensional aligned nanofibers-hydrogel scaffold for controlled non-viral drug/gene delivery to direct axon regeneration in spinal cord injury treatment.Cellular and paracellular transplants for spinal cord injury: a review of the literature.Drug delivery in soft tissue engineering.Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications.Biodegradable biomatrices and bridging the injured spinal cord: the corticospinal tract as a proof of principle.Regenerative medicine for the treatment of spinal cord injury: more than just promises?From molecular to nanotechnology strategies for delivery of neurotrophins: emphasis on brain-derived neurotrophic factor (BDNF)Receptor for advanced glycation end products (RAGE) and its ligands: focus on spinal cord injury.Progress of electrospun fibers as nerve conduits for neural tissue repair.Designer protein delivery: From natural to engineered affinity-controlled release systems.
P2860
Q24648585-BF35B4BF-0B21-446D-B0F9-89EA59E1E631Q26745909-8A09254E-CDF9-4EF5-896E-D7E64F01786EQ26826820-A2885553-54C6-49D5-A5E3-F0D42F21A011Q26829998-2A49E6E3-A6B4-4B48-80EB-C2FDFA5CC198Q26852370-37EBBCEC-3125-45C8-ABCB-179EDE596FFFQ26998135-6C71F51D-C828-4D83-9920-B98E1B367533Q27027789-EFD46D12-433E-47FA-AF0C-A02D5F5297D8Q30542430-A0AA8B20-B863-4D4E-BCC4-9A82E5DE96D2Q33252969-E72968E7-DF15-45FE-A955-51EC1E71ECE5Q33653678-1D3E7376-253F-4D71-A9A3-9D57B3498C41Q34285940-B08DF8CC-7955-4FAE-8E08-DCFE89E9FEFCQ34482943-0BB20E75-1DDF-4A02-B9B0-F8688188E47BQ35098949-4F68F0EB-A473-41A2-8B8C-3A99D8453687Q35208530-97CA8399-C119-4B09-BEB1-21CD1395CB3EQ35758158-AE0386CE-7A05-4C82-A896-DFD1A57E96F2Q35809691-713AA485-49E0-4F13-AF71-CA7B952022A8Q35812260-AA5FC978-2C43-49BD-B1EA-A19A355BD9EAQ35916978-C913AE34-02E4-44F6-A77A-3157C45AFF1DQ35990610-9F245290-D8F1-4ECF-BD81-33B54247142FQ35997113-12C3BF4D-4112-4813-AB8E-569C100C48B2Q36314939-1399643D-3FA3-4E3D-9945-D6BB9095EE43Q36317961-7F74BC17-8D25-4C3E-ADE4-F8D2DA6FD7B6Q36386002-07420E48-BCED-4F83-B968-BAAEE1CD7800Q36427255-D824E1DA-3FC2-4EEF-812D-6523EB869341Q36553094-65E58377-54B1-4357-A712-310B949D4D43Q36668673-76E1A5D0-FA79-4906-ACC4-6118BA3CF32FQ37042664-D1B832F0-7E33-418A-BA5C-DAEEC5CD27F2Q37428059-DEB3D082-E2B9-43D2-AF66-D2177E1CF390Q37456231-7762C6B7-5A9C-42E3-A1F0-F0BA68D84DABQ37471436-DE196CD7-20B3-4CAB-9B88-642F9843F078Q37627866-D232A6C4-9EAC-453D-A930-AED989E5B439Q37802780-AB01FA7C-72F2-4B16-8D6E-1FB59BEACD49Q37890406-987A3684-17CB-4373-B89C-C205F3DBA5BDQ37960809-5A5F61D1-B882-4ED2-ACB5-0E3830E04ECFQ37993008-941685A1-7411-428D-B6BB-A393C4D646AAQ38026986-A3C30B0E-C666-48B5-9931-EBB7A220E209Q38168376-AF548EDE-AC43-4A21-83CA-3D197661660BQ38234624-47241B64-82C6-42F6-BF8F-E63FC7028286Q38261056-3BF2F40A-66B8-4C0B-8641-D435EAF1FBF5Q38293159-36E9C06B-4F5C-48EB-862E-8ECB752891CE
P2860
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
@ast
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
@en
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
@nl
type
label
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
@ast
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
@en
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
@nl
prefLabel
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
@ast
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
@en
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
@nl
P2093
P1476
Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury.
@en
P2093
John W McDonald
Sara J Taylor
Shelly E Sakiyama-Elbert
P304
P356
10.1016/J.JCONREL.2004.05.003
P407
P577
2004-08-01T00:00:00Z